<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Myocardial cells in pulmonary veins are thought to play a major role in the initiation and maintenance of atrial <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, including <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In experiments on rat pulmonary veins, antiarrhythmic drug niferidil (RG-2) produced increase of APD90% and functional refractory period and decrease of action potential amplitude and slope of APD restitution curve </plain></SENT>
<SENT sid="2" pm="."><plain>Thus niferidil (RG-2) exerts stronger action on pulmonary veins than left atrium </plain></SENT>
<SENT sid="3" pm="."><plain>This can take important part in Niferidil (RG-2) antiarrhythmic activity </plain></SENT>
</text></document>